EDO’s Pharma RX TV Advertising Performance Insights Report for 2022 Upfront Planning

EDO provides advertisers with the tools to incorporate an outcome-based approach into the upfront planning process through our Search Engagement performance metrics, which measure actual consumer behavior in response to Linear TV ads.

Our Pharma RX TV Advertising Performance Insights Reports for 2022 Upfront Planning provides a sample of the data EDO delivers to help guide advertisers’ upfront investment decisions.

The report includes insights about:

  1. Top Pharma RX brands ranked by national TV ad spend and impressions.

  2. The top-performing shows and networks across broadcast and cable for Pharma RX ad effectiveness.

  3. The best live sports and awards programs for Pharma RX ad effectiveness.

  4. How EDO’s Pharma RX data can validate and maximize 2022 Linear TV upfront investment strategies.